SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 19 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,375 | -33.0% | 62,500 | 0.0% | 0.00% | – |
| Q2 2023 | $6,525 | +326150.0% | 62,500 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -33.3% | 62,500 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 62,500 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -66.7% | 62,500 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -60.0% | 62,500 | 0.0% | 0.00% | – |
| Q1 2022 | $30,000 | -73.2% | 62,500 | 0.0% | 0.00% | – |
| Q4 2021 | $112,000 | – | 62,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LMR Partners LLP | 387,588 | $272,000 | 0.01% |
| Radcliffe Capital Management, L.P. | 38,927 | $27,000 | 0.00% |
| Shaolin Capital Management LLC | 662,699 | $41,000 | 0.00% |
| EQUITEC PROPRIETARY MARKETS, LLC | 45,000 | $3,000 | 0.00% |
| Yakira Capital Management, Inc. | 108,485 | $7,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,621 | $0 | 0.00% |
| MARSHALL WACE, LLP | 247,576 | $173,000 | 0.00% |
| MORGAN STANLEY | 148,939 | $9,000 | 0.00% |
| Walleye Trading LLC | 15,505 | $1,000 | 0.00% |
| Citadel Advisors | 19,905 | $1,000 | 0.00% |